Open help menu
Live Webinar

Stellate Ganglion Block for Mental Health: A Cutting Edge Treatment Providers Need to Know

|

Information

Date & Time

Description

Discover how Stellate Ganglion Block (SGB) is transforming the mental health landscape. In this webinar, we’ll explore the science behind SGB, its impact on the nervous system, and its growing role in treating symptoms associated with PTSD, anxiety, and chronic stress. Designed for providers, this session will cover patient selection, expected outcomes, and how SGB can be integrated into a comprehensive care plan. Walk away with practical insights on when and how to consider this cutting-edge intervention for patients.

Educational Goal

The goal of this presentation is to equip healthcare providers with a clear, evidence-informed understanding of Stellate Ganglion Block (SGB) as an emerging intervention in mental health care. Participants will learn the underlying mechanism of action, appropriate patient selection, clinical indications (including PTSD and anxiety-related conditions), expected outcomes, and how to thoughtfully integrate SGB into a comprehensive, multidisciplinary treatment plan.

Learning Objectives

Participants will be able to:

  • Explain the mechanism of action of Stellate Ganglion Block (SGB) and its impact on the sympathetic nervous system.

  • Recognize appropriate patient selection criteria and clinical indications for the use of SGB in mental health treatment.

  • Assess the risks, benefits, and evidence-based outcomes associated with SGB for conditions such as PTSD and anxiety disorders.

  • Integrate SGB into clinical decision-making by identifying how it may complement existing pharmacologic and psychotherapeutic interventions within a comprehensive care plan.

Target Audience

  • Addiction Professional
  • Counselor
  • Marriage & Family Therapist
  • Nurse
  • Nurse Practitioner
  • Physician
  • Psychologist
  • Social Worker

Presenters

Gavin Dawson, PA-C is a board-certified Physician Assistant, educator, and healthcare innovator serving as the Director of Medical Operations at Stella Mental Health. He leads clinical strategy and provider training across multiple markets, helping to build an integrated model of psychiatric care that blends traditional psychiatry, psychotherapy, and advanced interventional treatments including TMS, ketamine, Spravato, and DSR. His leadership is grounded in a trauma-informed, patient-first philosophy that prioritizes compassionate communication, clinical excellence, and measurable outcomes. Across clinical leadership, education, and research, Gavin is driven by a single mission: to expand access to safe, evidence-based, and innovative treatments while empowering patients and providers alike to participate in a more transformative future for mental health care.

Financially Sponsored By

  • Stella Mental Health